Because our initial hypothesis – that CRP makes a limited contribution to the SDAI, and that excluding CRP from the SDAI will yield a simple and immediately calculable score – was supported by these statistical analyses, we next validated the CDAI using the cross-sectional 'routine' cohort and the independent, longitudinal inception cohort of patients with RA. The gene discussed is CRP; the disease is rheumatoid arthritis.